Cedar Mountain Advisors’s Aurora Cannabis ACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3 Hold
1
﹤0.01% 1173
2026
Q1
$3 Hold
1
﹤0.01% 1150
2025
Q4
$4 Hold
1
﹤0.01% 754
2025
Q3
$6 Hold
1
﹤0.01% 689
2025
Q2
$4 Hold
1
﹤0.01% 356
2025
Q1
$4 Hold
1
﹤0.01% 342
2024
Q4
$4 Hold
1
﹤0.01% 366
2024
Q3
$6 Sell
1
-13
-93% -$77 ﹤0.01% 331
2024
Q2
$63 Hold
14
﹤0.01% 331
2024
Q1
$60 Buy
14
+13
+1,300% +$50 ﹤0.01% 338
2023
Q4
$6 Hold
1
﹤0.01% 320
2023
Q3
$8 Hold
1
﹤0.01% 308
2023
Q2
$7 Hold
1
﹤0.01% 300
2023
Q1
$9 Hold
1
﹤0.01% 295
2022
Q4
$12 Hold
1
﹤0.01% 305
2022
Q3
$0 Hold
1
﹤0.01% 294
2022
Q2
$0 Hold
1
﹤0.01% 296
2022
Q1
$0 Hold
1
﹤0.01% 305
2021
Q4
$0 Hold
1
﹤0.01% 304
2021
Q3
$0 Hold
1
﹤0.01% 293
2021
Q2
$0 Hold
1
﹤0.01% 266
2021
Q1
$0 Sell
1
-17
-94% -$1.9K ﹤0.01% 268
2020
Q4
$1K Hold
18
﹤0.01% 249
2020
Q3
$1K Hold
18
﹤0.01% 229
2020
Q2
$2K Buy
18
+17
+1,700% +$1.93K ﹤0.01% 213
2020
Q1
$0 Hold
1
﹤0.01% 234
2019
Q4
$0 Buy
+1
New +$373 ﹤0.01% 242

Other funds holding ACB

Cedar Mountain Advisors's ACB Position: Q2 2026 in Review

Cedar Mountain Advisors held its Aurora Cannabis (ACB) position steady in Q2 2026 at 1 share worth $3. The position accounts for ﹤0.01% of the portfolio, ranked #1173.

Cedar Mountain Advisors first reported a position in ACB in Q4 2019 and has held it in 27 quarters since. The position peaked at $2K in Q2 2020. 149 funds tracked by Wall St. Rank hold ACB as of Q2 2026.

  • Cedar Mountain Advisors held 1 share of Aurora Cannabis worth $3 as of Q2 2026.
  • Cedar Mountain Advisors left its Aurora Cannabis share count unchanged in Q2 2026.
  • Aurora Cannabis made up ﹤0.01% of Cedar Mountain Advisors's portfolio in Q2 2026, its #1173 holding.
  • Cedar Mountain Advisors first reported a position in Aurora Cannabis in Q4 2019 and has held it in 27 quarters since.
  • Cedar Mountain Advisors's Aurora Cannabis position peaked at $2K in Q2 2020.
  • 149 funds tracked by Wall St. Rank held Aurora Cannabis as of Q2 2026.

Based on Cedar Mountain Advisors's 13F filing for Q2 2026, filed 2 Jul 2026.